These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32529863)

  • 1. Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.
    Zhai C; Hou K; Li R; Hu Y; Zhang J; Zhang Y; Wang L; Zhang R; Cong H
    J Int Med Res; 2020 Jun; 48(6):300060520926349. PubMed ID: 32529863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.
    Naci H; Brugts JJ; Fleurence R; Tsoi B; Toor H; Ades AE
    Eur J Prev Cardiol; 2013 Aug; 20(4):641-57. PubMed ID: 23447425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
    Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
    BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.
    Khan SU; Talluri S; Riaz H; Rahman H; Nasir F; Bin Riaz I; Sattur S; Ahmed H; Kaluski E; Krasuski R
    Eur J Prev Cardiol; 2018 May; 25(8):844-853. PubMed ID: 29569492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials.
    Koskinas KC; Siontis GCM; Piccolo R; Mavridis D; Räber L; Mach F; Windecker S
    Eur Heart J; 2018 Apr; 39(14):1172-1180. PubMed ID: 29069377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.
    Teng M; Lin L; Zhao YJ; Khoo AL; Davis BR; Yong QW; Yeo TC; Lim BP
    Drugs Aging; 2015 Aug; 32(8):649-61. PubMed ID: 26245770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
    Tramacere I; Boncoraglio GB; Banzi R; Del Giovane C; Kwag KH; Squizzato A; Moja L
    BMC Med; 2019 Mar; 17(1):67. PubMed ID: 30914063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis.
    Zhong P; Wu D; Ye X; Wu Y; Li T; Tong S; Liu X
    Drug Des Devel Ther; 2017; 11():2517-2526. PubMed ID: 28919704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid lowering for secondary prevention of cardiovascular disease in older adults.
    Thomas JE; Tershakovec AM; Jones-Burton C; Sayeed RA; Foody JM
    Drugs Aging; 2010 Dec; 27(12):959-72. PubMed ID: 21087066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.
    de Vries FM; Denig P; Pouwels KB; Postma MJ; Hak E
    Drugs; 2012 Dec; 72(18):2365-73. PubMed ID: 23186103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Statins Prescribed for Primary and Secondary Prevention and Major Adverse Cardiac Events among Older Adults with Frailty: A Systematic Review.
    Hale M; Zaman H; Mehdizadeh D; Todd O; Callaghan H; Gale CP; Clegg A
    Drugs Aging; 2020 Nov; 37(11):787-799. PubMed ID: 32929609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
    Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and the elderly: recent evidence and current indications.
    Schiattarella GG; Perrino C; Magliulo F; Ilardi F; Serino F; Trimarco V; Izzo R; Amato B; Terranova C; Cardin F; Militello C; Leosco D; Trimarco B; Esposito G
    Aging Clin Exp Res; 2012 Jun; 24(3 Suppl):47-55. PubMed ID: 23160507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
    Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
    Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
    Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
    BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence.
    Ali R; Alexander KP
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):52-63. PubMed ID: 17608248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.